BARTELS CYTOMEGALOVIRUS IMMED. EARLY ANTIGEN— 510(k) K904036

Substantially Equivalent

Baxter Healthcare Corp

FDA 510(k) clearance K904036 for BARTELS CYTOMEGALOVIRUS IMMED. EARLY ANTIGEN, Substantially Equivalent on 1990-10-16. Applicant: Baxter Healthcare Corp.

Clearance details

Applicant: Baxter Healthcare Corp
Product code: Code LIN
Advisory panel: Microbiology
Date received: 1990-09-05
Decision date: 1990-10-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Bellevue, WA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.